Studies related to Gestational Diabetes Risk and Inositol

Myo-inositol May Prevent Gestational Diabetes In PCOS Women

Effect Decrease
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 83
Sex Female
Age Range 18-29, 30-44
Body Types Obese
Notes for this study:
Supplementation of myo-inositol throughout pregnancy is associated with less risk of developing gestational diabetes (54% occurrence reduced to 17.2%) in women who also have PCOS. The final odds ratio was 2.4, indicating a more than double risk with placebo relative to inositol at 4,000mg daily

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.